No Data
Nikkei Average Contribution Ranking (Preliminary Close) - The Nikkei Average significantly rose for three consecutive days, with Fast Retailing boosting it by about 85 yen from one stock.
As of the market close 27 days ago, the number of rising and falling stocks in the Nikkei average was 190 up, 34 down, and 1 unchanged. The Nikkei average has risen for three consecutive days. It finished the morning session at ¥40,074.56, up ¥506.50 (+1.28%) compared to the previous day (estimated Volume of 0.9 billion 30 million shares). The US stock market on the 26th was mixed. The Dow Inc was up $28.77 at $43,325.80, while the Nasdaq ended down 10.77 points at $20,020.36. Unemployment Insurance.
Sumitomo Heavy Industries To Go Ex-Dividend On December 27th, 2024 With 65 JPY Dividend Per Share
December 26th (Japan Standard Time) - $Sumitomo Heavy Industries(6302.JP)$ is trading ex-dividend on December 27th, 2024.Shareholders of record on December 31st, 2024 will receive 65 JPY dividend
Establishment of the "Sumitomo Heavy Equipment Group Basic Policy on Compliance with Antimonopoly Laws".
On December 26, 2024, the company group requires Company Executives and employees to thoroughly adhere to laws and corporate ethics, while consistently acting with high sense of propriety. In recent years, with the further Global expansion of the business, efforts have been made to strengthen the framework for compliance with international antitrust laws as an important issue for the entire group. This time, the company group has clarified the rules for antitrust compliance that Company Executives and employees must follow in order to prevent violations of antitrust laws.
Fujita Medical University, Atlancent Pharma, Stella Pharma, and Fujita have signed a memorandum regarding boron neutron capture therapy.
On December 25, 2024, Sumitomo Heavy Industries, Ltd. (Headquarters: Shinagawa, Tokyo; President: Shinji Shimomura, hereinafter referred to as "the company") announced partnerships with Fujita Medical University (Headquarters: Toyoake, Aichi Prefecture; Chairman: Kiyotaka Hoshinaga, hereinafter referred to as "Fujita Medical University"), Atransen Pharma Co., Ltd. (Headquarters: Osaka City, Osaka Prefecture; CEO: Tomoyuki Asano, hereinafter referred to as "Atransen Pharma"), and Stella Pharma Co., Ltd. (Headquarters: Osaka City, Osaka Prefecture; President: Koki Uehara).
Three key points to watch in the first half of the session - movements aimed at short-term price fluctuations in Australian Small/Mid Cap stocks.
In today's morning Trade, I would like to focus on the following three points. ■ Short-term price range targeting movements in Australian Small/Mid Cap stocks ■ Japan Oracle Corp, 2Q operating profit increased by 9.4% to 41.9 billion yen ■ Notable materials from the morning: Sumitomo Heavy, strategic investment of 10 billion yen in Niihama, new building with design consolidation for transport systems ■ Short-term price range targeting movements in Australian Small/Mid Cap stocks. On the 23rd, the Japanese stock market is likely to start slightly with Buy ahead, but it seems that the market will develop with a strong sense of stagnation. In the US market on the 20th, the Dow Jones Industrial Average was at 4.
OpenAI enters the "war Business".
It has been reported that OpenAI has partnered with defense technology startup Anduril Industries to provide technology for anti-Drone defense systems for the U.S. military. This marks OpenAI's deepest engagement with the Department of Defense to date and is said to be its first partnership with a weapons manufacturer. <7011>Mitsubishi Heavy Industries <7012>Kawasaki Heavy Industries <6503>Mitsubishi Electric Corp. Unsponsored ADR <7270>SUBARU CORP Unsponsored ADR <
